Page 185 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 6

REFERENCES

1. Halpern NA, Pastores SM. Critical care medicine in the United 17. From the bench to the bedside: the future of sepsis research.
States 2000-2005: an analysis of bed numbers, occupancy rates, Executive summary of an American College of Chest
payer mix, and costs. Crit Care Med. 2010;38:65-71. Physicians, National Institute of Allergy and Infectious Disease,
2. Patient Protection and Affordable Care Act. In: Pub L 111-148. and National Heart, Lung, and Blood Institute Workshop. Chest.
United States; 2010. 1997;111:744-753.
3. Arrow KJ. Uncertainty and the welfare economics of medical 18. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insu-
care. Am Econ Rev. 1963;53:941-973. lin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
4. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term 19. Angus DC, Carlet J; 2002 Brussels Roundtable Participants.
“cost effective” in medicine. N Engl J Med. 1986;314:253-256. Intensive Care Med. 2003;29(3):368-377.
5. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. 20. Angus DC, Carlet J; Participants BR. Surviving intensive care: a
The role of cost-effectiveness analysis in health and medicine. report from the 2002 Brussels Roundtable. Intensive Care Med.
JAMA. 1996;276:1172. 2003;29:368-377.
6. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations 21. Angus DC, Linde-Zwirble WT, Sirio CA, et al. The effect of
for reporting cost-effectiveness analyses. JAMA. 1996;276:1339. managed care on ICU length of stay: Implications for Medicare.
JAMA. 1996;276:1075.
7. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB.
Recommendations of the panel on cost-effectiveness in health 22. Chelluri L, Pinsky MR, Donahoe MP, Grenvik A. Long-term
and medicine. JAMA. 1996;276:1253. outcome of critically ill elderly patients requiring intensive care.
JAMA. 1993;269:3119-3123.
8. Understanding costs and cost-effectiveness in critical care: report
from the second American Thoracic Society workshop on out- 23. Desai SV, Law TJ, Needham DM. Long-term complications of
comes research. Am J Respir Crit Care Med. 2002;165(4):540-550. critical care. Crit Care Med. 2011;39:371-379.
24. Ehlenbach WJ, Hough CL, Crane PK, et al. Association between
9. Drummond M, Sculpher M, Torrance G. Methods for the
economic evaluation of health care programme. Third edition. acute care and critical illness hospitalization and cognitive func-
Oxford University Press; 2005. tion in older adults. JAMA. 2010;303:763-770.
25. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cogni-
10. Gold MR. Siegel JE, Russell LB, et.al Cost-Effectiveness in Health tive impairment and functional disability among survivors of
and Medicine. Oxford University Press; 1996.
severe sepsis. JAMA. 2010;304:1787-1794.
11. Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide 26. Khouli H, Astua A, Ahmad F, et al. Changes in health-related
therapy for persistent pulmonary hypertension of the newborn. quality of life and factors predicting long-term outcomes in
N Engl J Med. 2000;342:469-474.
older adults admitted to intensive care units. Crit Care Med.
12. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric 2011;39(4):731-737.
oxide in full-term and nearly full-term infants with hypoxic 27. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude
respiratory failure. N Engl J Med. 1997;336:597-604.
and duration of the effect of sepsis on survival. Department of
13. Gafni A, Birch S. Incremental cost-effectiveness ratios (ICERs): Veterans Affairs Systemic Sepsis Cooperative Studies Group.
the silence of the lambda. Soc Sci Med. 2006;62:2091-2100. JAMA. 1997;277:1058-1063.
14. Diamond GA, Kaul S. Cost, effectiveness, and cost-effectiveness. 28. Wunsch H, Guerra C, Barnato AE, Angus DC, Li G, Linde-
Circ Cardiovasc Qual Outcomes. 2009;2:49-54. Zwirble WT. Three-year outcomes for Medicare beneficiaries
15. Angus DC, Clermont G, Watson RS, Linde-Zwirble WT, who survive intensive care. JAMA. 2010;303:849-856.
Clark RH, Roberts MS. Cost-effectiveness of inhaled nitric 29. Kahn JM, Rubenfeld GD, Rohrbach J, Fuchs BD. Cost savings
oxide in the treatment of neonatal respiratory failure in the attributable to reductions in intensive care unit length of stay for
United States. Pediatrics. 2003;112:1351-1360. mechanically ventilated patients. Med Care. 2008;46:1226-1233.
16. Freemantle N, Drummond M. Should clinical trials with 30. Kahn JM, Benson NM, Appleby D, Carson SS, Iwashyna TJ.
concurrent economic analyses be blinded? JAMA. 1997;277: Long-term acute care hospital utilization after critical illness.
63-64. JAMA. 2010;303:2253-2259.

Section01-O-ref.indd 1 12/10/2014 8:06:38 PM